Swetha RaniKanduri Ochsner Health, New Orleans, LAUnited States

Swetha RaniKanduri
I am Swetha Kanduri, completed medical school from Osmania medical college in India, residency from University of Alabama and Fellowship from University of Mississippi Medical Center. Currently working as Assistant Professor at Ochsner Health and serves as Associate Fellowship Program Director for the Nephrology Fellowship Program. Research Interest in Hepatorenal syndrome and Onco-Nephrology with particular focus on electrolyte abnormalities in cancer patients, GLP-1RA in cancer patients ________________________________________
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/d195a7b7d7c5a9ccca222bf401e21952.jpeg
First Name
Swetha Rani
Last Name
Kanduri
Institution
Country.
United States

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
Looking into the Crystal Ball – Where Will We Be 5 Years from Now?
RajkumarSharma Chair Director and Head of Department of Nephrology, Medanta Hospital, Lucknow India
Swetha RaniKanduri Chair Ochsner Health, New Orleans, LAUnited States
  • Evaluating Kidney Allograft Dysfunction
    SumitMohan Speaker Columbia UniversityUnited States
  • Advances in Glomerular Disease Treatment
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Risk Prediction in AKI and CKD
    NavdeepTangri Speaker University of Manitoba, SOGH Chronic Disease Innovation CentreCanada
  • Prioritizing Patient-friendly Dialysis
    EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom
  • Glomerular Disease Diagnostics
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Q&A
Brahmkamal Hall - Plenary Hall

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
Metabolic Crossroads: Kidneys, Liver Disease, and the Gut
GloriaAshuntantang Chair University of Bamenda, CameroonCameroon
Narayan Prasad Chair Sanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India India
Dr Sree BhushanRaju Chair India
  • Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis
    Swetha RaniKanduri Speaker Ochsner Health, New Orleans, LAUnited States
  • Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it?
    GrietGlorieux Speaker UGentBelgium
  • What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Measuring Kidney Function in Liver Disease - Pitfalls and Solutions
    SmitaDivyaveer Speaker POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIAIndia
  • Q&A
Amaltas Hall B101-A